Gliatilin solution for injection (Choline alfoscerate) 1000 mg/4 ml 3 ampoules Глиатилин Brain diseases

Gliatilin Indications

Acute period of severe traumatic brain injury with predominantly stem level of damage (disturbance of consciousness, coma, focal hemispheric symptoms, symptoms of brain stem damage).

Degenerative-involutional cerebral psychoorganic syndromes or secondary consequences of cerebrovascular insufficiency, ie primary and secondary mental disorders in the elderly, characterized by memory impairment, confusion, disorientation, decreased motivation and initiative, decreased ability to concentrate; changes in the emotional sphere and the sphere of behavior: emotional instability, irritability, indifference to the environment; pseudomelancholia in the elderly.

Contradictions

Hypersensitivity to the drug or its components.

Psychotic syndrome, severe psychomotor agitation.

Pregnancy or breastfeeding.

Dosage & Administration

In acute conditions Gliatilin administered intramuscularly or intravenously (slowly) 1 g (1 ampoule) per day for 15 to 20 days. Then, after stabilization of the patient's condition, switch to the dosage form of the drug in capsules.

Children. There is no experience of using Gliatilin in children.